透過您的圖書館登入
IP:3.147.46.58
  • 學位論文

對於5’-amino uridine衍生物分子庫的直接生物分析

A direct bioassay for a library of 5’-amino uridine derivates

指導教授 : 俞鐘山

摘要


為了準備衍生物分子庫的溶液,我們應用目前常用的簡單方法,快速多樣性導向amide forming反應。這些化合物透過5’-amino-uridine和24種carboxylic acid之間的耦合反應被合成出來,接著在沒有生成物純化的情況下,直接進行細胞毒性分析。我們希望這個新發展中的方法可以針對癌症治療篩選出有潛力的藥物。人類非小細胞肺腫瘤細胞A549是我們當作目標的選擇。為了排除溶劑DMF對於A549的毒性,被採用策略是藉由加入鹽酸使DMF變成一個四級胺鹽。雖然這樣處理克服DMF的毒性,但是結果是A549生長在pH=4與pH=5之間的異常生理狀態。因此,MTT分析在這個狀況之下沒有辦法被實行而且利用我們藉由全光譜分析了這些原因。細胞存活率只能以顯微鏡觀察紀錄下來。更幸運的是,被使用的試劑似乎對於A549沒有毒性。最後,在24種溶液當做藥物被加入含有A549的96孔盤之中,我們沒有發現任何一個具有明顯細胞毒性。在我們粗略地完成一些試驗之後,仍然有許多的問題和困難必須被克服而且使整個實驗的概念更理想化。

關鍵字

二甲基乙醯胺 A549

並列摘要


We apply a current simple method, quick diversity-oriented amide-forming reaction, for preparation in solution of a library of compounds. These compounds are synthesized through a coupling reaction between a 5’-amino uridine and 24 kinds of carboxylic acids, followd by a direct assay of cytotoxicity without product purification. We hope that this innovative developing approach can screen potential drugs for cancer therapy. The human non-small cell lung tumor cell A549 is our choice as a targer. In order to eliminate the toxicity of solvent DMF (dimethylformamide) to A549, one strategy adopted is to make DMF become a quaternary salt by adding HCl. Althoughg this treatment overcomes the toxicity of DMF, the effect is the abnormal physiological condition where A549 growing is between pH=4 and pH=5. Therefore, MTT assay isn’t carried out under this condition, and we analyze the reasons by full spectrum. The cell viability is recorded only with microscopic observation. More fortunately, the reagents used seem not to be toxic to A549. Finally, among the 24 kinds of solutions as drugs added into 96-well plate containing A549, we don’t find out anyone possessing apparent cytotoxicity. After we roughly completed these tests, there are still many problems and difficulties have to be overcomed and make the whole experimental concept more optimized.

並列關鍵字

DMF A549

參考文獻


(7) Haarr, L., and T. Flatmark., J. Gen. Virol. 1987, 68:2817–2829.
(14) Moolten, F. L., and Wells, J. M., J. Natl. Cancer Inst. 1990, 82, 297–300.
(28) Denning, C., and Pitts, J. D., Hum. Gene Ther. 1997, 8, 1825–1835.
(38) Altered gap junctional communication, intercellular signaling, and growth in cultured astrocytes deficient in connexin43.; Naus, C. C., Bechberger, J. F., Zhang, Y., Venance, L., Yamasaki, H., Juneja, S. C., Kidder, G. M., and Giaume, C., Ed.; Vol. J. Neurosci. Res. 1997, 49, 528–540.
(48) T., H., Nat Med. 2000, 6, 6.

延伸閱讀